Nihon Kohden (OTCMKTS:NHNKY) Stock Price Breaks Above 200 Day Moving Average - Should You Sell?

Key Points

• Nihon Kohden shares rose above their 200-day moving average, reaching $10.53 before last trading at $10.115, compared with the average of $9.85.
• UBS downgraded the stock from “strong buy” to “hold”; both covering analysts now rate it Hold, giving the company an average Hold rating.
• The company’s latest quarter fell short of expectations, reporting a loss of $0.03 per share versus projected EPS of $0.06 and revenue of $297.47 million versus $299.98 million expected.

Shares of Nihon Kohden Corporation (OTCMKTS:NHNKY - Get Free Report) crossed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $9.85 and traded as high as $10.53. Nihon Kohden shares last traded at $10.1150, with a volume of 12,338 shares trading hands.

Analyst Upgrades and Downgrades

Separately, UBS Group downgraded Nihon Kohden from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, August 12th. Two analysts have rated the stock with a Hold rating. According to MarketBeat, the stock currently has an average rating of "Hold".

Nihon Kohden Price Performance

The firm has a 50-day moving average of $9.92 and a 200-day moving average of $9.85. The stock has a market cap of $1.70 billion, a PE ratio of 18.39 and a beta of 0.38. The company has a debt-to-equity ratio of 0.12, a current ratio of 3.98 and a quick ratio of 2.64.

Nihon Kohden (OTCMKTS:NHNKY - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported ($0.03) EPS for the quarter, missing the consensus estimate of $0.06 by ($0.09). The company had revenue of $297.47 million during the quarter, compared to analysts' expectations of $299.98 million. Nihon Kohden had a return on equity of 9.17% and a net margin of 5.90%. Research analysts predict that Nihon Kohden Corporation will post 0.60 EPS for the current year.

About Nihon Kohden

Nihon Kohden Corporation is a Japanese medical technology company that develops, manufactures and markets electronic medical equipment and related solutions. Founded in 1951 and headquartered in Tokyo, the company serves hospitals, clinics and other healthcare providers through operations in Japan and international markets.

Its product portfolio includes patient monitoring systems, electrocardiographs, electroencephalographs and other neurological diagnostic equipment. Nihon Kohden also supplies defibrillators, automated external defibrillators, ventilators, anesthesia-related equipment, clinical information systems and devices used in in-vitro diagnostics, including hematology testing.

The company distributes its products through domestic and overseas subsidiaries, distributors and service networks.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.